Table: Medipal Holdings - 9-MTH group results
Feb 10 (Reuters)-
Medipal Holdings Corp
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2024 Dec 31, 2023 Mar 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 2.81 trln 2.71 trln 3.66 trln
(+3.4 pct) (+5.7 pct) (+2.8 pct)
Operating 45.37 37.22 50.00
(+21.9 pct) (-0.8 pct) (+5.6 pct)
Recurring 56.71 50.24 66.00
(+12.9 pct) (+0.7 pct) (+2.2 pct)
Net 36.24 28.29 33.50
(+28.1 pct) (-5.2 pct) (-19.2 pct)
EPS 173.66 yen 133.19 yen 160.68 yen
Ann Div 60.00 yen 60.00 yen
-Q2 div 30.00 yen 30.00 yen
-Q4 div 30.00 yen 30.00 yen
NOTE - Medipal Holdings Corp.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7459.T
Recent news on Medipal Holdings
See all newsBrief: Medipal Holdings Corp Says It Will Buy Back Up To 2% Of Own Shares Worth 10 Billion Yen
Table: Medipal Holdings -2026/27 group forecast
Brief: Medipal Holdings Announces It Has Received Demand For EGM From Shareholder Silchester International Investors
Brief: Silchester International Raises Stake In Medipal Holdings Corp To 11.96% From 11.73%, Filing Shows
Brief: Silchester To Make Proposals Regarding Higher Dividend, Share Buyback, Share Retirement, Composition Of Board Of Directors If No Improvement In Dialogue With Medipal Holdings, Filing Shows